[Ip-health] New Tufts study on R&D costs

Robert Weissman rweissman at citizen.org
Fri Nov 14 10:01:57 PST 2014


$1.826 billion. 

Actually, $1.826748 billion.


Robert Weissman
President 
Public Citizen
1600 20th St., NW
Washington, DC 20009
Tel: 202-588-1000 | Email: rweissman at citizen.org



-----Original Message-----
From: Ip-health [mailto:ip-health-bounces at lists.keionline.org] On Behalf Of Jamie Love
Sent: Friday, November 14, 2014 12:35 PM
To: Ip-health
Subject: [Ip-health] New Tufts study on R&D costs

Next week, a new version of the Tufts study on R&D costs will be released.

KEI will give $50 to the person who comes the closed in predicting the new figure for the cost of R&D for the lead indication of a new chemical entity.

An abstract of the earlier 2003 study,"The price of innovation: new estimates of drug development costs" is available here:

http://www.ncbi.nlm.nih.gov/pubmed/12606142


The 2003 study put the number at $802 million (not $800 million, but $802 million), in 2000 dollars.

As I said, $50 for the closest estimate, published on IP-Health, before the new number is announced (or leaked).

Jamie

--
James Love.  Knowledge Ecology International http://www.keionline.org/donate.html
KEI DC tel: +1.202.332.2670, US Mobile: +1.202.361.3040, Geneva Mobile:
+41.76.413.6584, twitter.com/jamie_love
_______________________________________________
Ip-health mailing list
Ip-health at lists.keionline.org
http://lists.keionline.org/mailman/listinfo/ip-health_lists.keionline.org




More information about the Ip-health mailing list